Organisation · Unternehmen
Xellia Pharmaceuticals
xellia-pharmaceuticals-eutr-45281564
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-24599]
eu transparency goals
Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infectives. We manufacture and supply APIs as well as Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries.
The World Health Organization and the European Union recognize a variety of our products as essential and critical medicines, serving as crucial resources in the fight against severe infections and antimicrobial resistance.
Headquartered in Copenhagen, Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Denmark, Hungary, and China, alongside R&D and commercial operations in an additional eight locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.
The World Health Organization and the European Union recognize a variety of our products as essential and critical medicines, serving as crucial resources in the fight against severe infections and antimicrobial resistance.
Headquartered in Copenhagen, Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Denmark, Hungary, and China, alongside R&D and commercial operations in an additional eight locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.
dokumentiert
[Q-24599]
eu transparency id
615015452815-64
dokumentiert
[Q-7535]
headquarters city
Copenhagen S
dokumentiert
[Q-24599]
headquarters country
DE
dokumentiert
[Q-24599]
interest class
business_company
dokumentiert
[Q-29773]
legal form
ApS
dokumentiert
[Q-24599]
legal form class
unbekannt
berichtet
[Q-29775]